Who
Baiteng Zhao
Director
Company insider
Files Form 4 as: Director, Whitehawk Therapeutics.
In numbers
- Trades disclosed
- 5
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 19 Dec 2024
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,040 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,040 at $0.00 | filing |
| 17 Jun 2025filed 17 Jun 2025 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,006 at $0.00 | filing |
| 4 Mar 2025filed 4 Mar 2025 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $3.0M1,250,000 at $2.40 | filing |
| 19 Dec 2024filed 23 Dec 2024 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —61,192 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.